Sedulo Group — Recent Moves (11 tracked, last 90 days)

Sedulo Group is a competitive and market intelligence consultancy whose recent output centres on frameworks, case studies and assessment tools for CI and strategy teams. Its moves point to a firm building a visible thought-leadership library rather than selling a software platform. The mix spans life sciences, cybersecurity, diagnostics and B2B deal desk work.

Sedulo Group has been tracked across 11 moves since early August 2026, with none yet confirmed. That volume of publishing in a short window matters for anyone benchmarking CI vendors. It signals an active push to own the language of intelligence maturity and counterintelligence.

Thought leadership as the front door: Sedulo Group has been steadily filling a content library. It added a 2026 Life Sciences CI Survey Report in late September and published an acute migraine competitive intelligence case study in late August. New case studies for cybersecurity and diagnostics D2C followed in early August. The pattern suggests a firm using published research to generate inbound demand rather than paid acquisition.

Productising its methods: Sedulo Group is turning consulting know-how into reusable assets. It launched a Strategic Intelligence Maturity Assessment Tool in mid August and a framework for B2B deal desk implementation in early August. Strategic wargaming and market landscape assets were made available around the same time. This signals a shift toward scalable, self-serve diagnostics that qualify buyers before a conversation.

Defensive and counterintelligence positioning: Sedulo Group is carving out a distinctive niche. In mid August it positioned counterintelligence auditing for defensive strategy. That sits alongside its maturity assessment and wargaming assets as a coherent defensive toolkit. The framing targets organisations worried about being outmanoeuvred, not just informed.

Event-led go-to-market: Sedulo Group is anchoring visibility to live industry moments. It announced a performance presentation for Pharma CI Europe 2026 in mid August. A pharma marketing positioning framework for crowded markets was featured from early July. Its homepage now leads with competitive, market intelligence and strategy consulting. Together these moves show a firm aligning web presence, events and content around a single consulting identity.

What to watch: Watch whether Sedulo Group converts its assessment tool and frameworks into repeatable engagements. Watch for further life sciences and pharma content, given the Pharma CI Europe 2026 presentation. Any move from published assets toward a packaged offering would mark a meaningful strategic step.